World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
RNA-guided CRISPR system activates gene expression

RNA-guided CRISPR system activates gene expression

by admin | Apr 3, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Alisha Willett, Purdue University – PHYS.ORG – In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally evolved gene-editing system that can activate genes, offering an advantage over...
Leveraging the Full Potential of Regenerative Medicine Requires a Proactive Approach

Leveraging the Full Potential of Regenerative Medicine Requires a Proactive Approach

by admin | Apr 2, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Genetic Engineering & Biotechnology News – Modern medicine has achieved extraordinary success in treating acute disease. Yet when it comes to chronic degenerative conditions, the diseases that dominate healthcare spending and disability in aging...
Implantable islet cells could control diabetes without insulin injections

Implantable islet cells could control diabetes without insulin injections

by admin | Apr 1, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Anne Trafton | MIT News – The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows. Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple...
With FDA go ahead, a China biotech notches a first in cell therapy testing

With FDA go ahead, a China biotech notches a first in cell therapy testing

by admin | Mar 31, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Jacob Bell – BioPharmaDive – The agency has now cleared Shanghai-based Unixell to begin human studies in the U.S. for an allogeneic, stem cell-derived therapy targeting focal epilepsy. For the first time, the Food and Drug Administration is allowing a...
Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells

Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells

by admin | Mar 30, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Ritsuko Kawa – Wired – Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology. On March 6, Japan’s Ministry of Health,...
Page 3 of 181«12345...102030...»Last »

Recent Posts

  • Improving CAR-T therapy from within
  • ‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?
  • Scientists create “smart” DNA drug that targets cancer cells with extreme precision
  • Patient deaths prompt concern over regenerative care not covered by insurance
  • Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
  • Clinical trial tests new cell therapy to manage kidney transplant rejection
World Stem Cell Summit Logo - White version
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow